AR039901A1 - Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol - Google Patents

Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol

Info

Publication number
AR039901A1
AR039901A1 ARP030101885A ARP030101885A AR039901A1 AR 039901 A1 AR039901 A1 AR 039901A1 AR P030101885 A ARP030101885 A AR P030101885A AR P030101885 A ARP030101885 A AR P030101885A AR 039901 A1 AR039901 A1 AR 039901A1
Authority
AR
Argentina
Prior art keywords
pentan
metabolite
phenyl
methyl
metoxi
Prior art date
Application number
ARP030101885A
Other languages
English (en)
Inventor
Joerg Holenz
Burkhard Kurth
Oswald Zimmer
Thomas Christoph
Helmut Buschmann
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR039901A1 publication Critical patent/AR039901A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/72—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with quaternised amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/62—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/72—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Metabolito a partir de 1-dimetilamino-3(3-metoxi-fenil)-2-metil-pentan-3-ol seleccionado entre fórmulas 1 a 20 en donde, según el caso en forma de sus racematos, sus estereoisómeros puros, en especial enantiómeros o diastereómeros, o en forma de mezclas de estereoisómeros, en especial de enantiómeros o diastereómeros, en cualquier relación de mezcla; en forma pura o en forma de sus ácidos o de sus bases, o en forma de sus sales, en especial las sales fisiológicamente admisibles, o en forma de sus solvatos, en especial de los hidratos. Uso de dichos metabolitos para preparar medicamentos y dichos medicamentos de aplicación en el tratamiento del impulso aumentado de orinar o de la incontinencia urinaria.
ARP030101885A 2002-05-30 2003-05-29 Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol AR039901A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10224624A DE10224624A1 (de) 2002-05-30 2002-05-30 Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol

Publications (1)

Publication Number Publication Date
AR039901A1 true AR039901A1 (es) 2005-03-09

Family

ID=29432607

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101885A AR039901A1 (es) 2002-05-30 2003-05-29 Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol

Country Status (6)

Country Link
EP (1) EP1507521A1 (es)
AR (1) AR039901A1 (es)
AU (1) AU2003238398A1 (es)
DE (1) DE10224624A1 (es)
PE (1) PE20040521A1 (es)
WO (1) WO2003101440A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2901180A1 (de) * 1979-01-13 1980-07-24 Basf Ag Hexahydro-1,4-oxazepine, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
WO2003101440A1 (de) 2003-12-11
DE10224624A1 (de) 2003-12-11
PE20040521A1 (es) 2004-08-24
AU2003238398A1 (en) 2003-12-19
EP1507521A1 (de) 2005-02-23

Similar Documents

Publication Publication Date Title
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
ES2486866T3 (es) Dispositivo ortopédico para corregir posiciones defectuosas de los dedos del pie
UY28514A1 (es) Nuevos compuestos
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
UY27446A1 (es) Nuevos compuestos
AR042437A1 (es) Derivados de fluoroglicosidos heterociclicos, medicamentos que los contienen y usos
AR042097A1 (es) Uso de de eritropoyetina para el tratamiento de los trastornos de l a distribucion de hierro en las enfermedades cardiacas
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
SE0302487D0 (sv) Novel compounds
PA8545301A1 (es) Nuevos derivados de quinolina
SV2002000342A (es) Inhibidor de la glucogeno fosforilasa ref. pc.10753/20151/bb
ES2421744T3 (es) Válvula cardíaca reposicionable
DE602005026945D1 (de) Expandierbares Medizinprodukt zur Abgabe eines Heilmittels
UY28510A1 (es) Compuestos quimicos
UY28348A1 (es) Compuestos novedosos
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
CR7042A (es) Indanil aminas aciladas y su uso como farmacos
HRP20050439B1 (en) New use of dextran sulfate
AR024998A1 (es) Nuevos retinoides para el tratamiento del enfisema
UY27700A1 (es) Compuestos oxo - azabiclícos.
AR044453A1 (es) Derivados de metoxi-pirazin-tienil sulfonamida
AR041339A1 (es) Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen
AR041865A1 (es) Derivados terapeuticos de prolina y su uso en el tratamiento de epilepsia y dolor
AR039901A1 (es) Metabolito a partir de 1-dimetilamino-3-(3-metoxi-fenil)-2-metil-pentan-3-ol
AR025351A1 (es) Agonistas retinoides selectivos par

Legal Events

Date Code Title Description
FB Suspension of granting procedure